
Stramsen Biotech: A biopharmaceutical firm innovating medicines through a natural plant-based approach.
Stramsen Biotech, founded in November 2020 and based in Houston, Texas, is a biopharmaceutical company dedicated to developing medicines using a natural plant-based approach. The company's core mission is to address both infectious and non-infectious diseases through innovative scientific methods. Stramsen Biotech aims to leverage the wonders of plant-based science to create effective and sustainable medical solutions, targeting a broad market that includes patients suffering from various ailments.
Notable figures affiliated with Stramsen Biotech include its CEO, board members, and investors who are committed to advancing the company's mission. Since its inception, Stramsen Biotech has made significant strides in the biopharmaceutical field, contributing to the development of novel treatments. The company's impact is reflected in its growing portfolio of plant-based medicines, which promise to offer safer and more natural alternatives to conventional pharmaceuticals.

Strm.Bio
strm.bio
Blended BioHealth

Marlinspike Therapeutics

Lamassu Pharma
lamassupharma.com

Stream Biomedical

Faze Medicines
fazemed.com

Regenerative Bio
regen-bio.us

Sporos Bioventures

Generate Biomedicines

BiotechInnova
biotechinnova.com

Petri Bio
petribio.com

Solarea Bio
solareabio.com

Surf Bio
surf.bio

Enveda Biosciences
envedabio.com

Brii Biosciences
briibio.com
Companies similar to Stramsen Biotech include Strm.Bio, Blended BioHealth, Marlinspike Therapeutics and Lamassu Pharma.
Stramsen Biotech was founded in 2020.
Stramsen Biotech's headquarters is located in Houston, TX, US.
Stramsen Biotech's most recent funding round was for $10M (USD) in October 2023.
As of Oct 20, 2023, Stramsen Biotech has raised a total of $10M (USD).
Stramsen Biotech has 30 employees as of Feb 4, 2024.